These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9189868)

  • 1. Considerations for the treatment of secondary hyperparathyroidism in renal failure.
    Felsenfeld AJ
    J Am Soc Nephrol; 1997 Jun; 8(6):993-1004. PubMed ID: 9189868
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits of calcitriol therapy and serum phosphorus control in dogs and cats with chronic renal failure. Both are essential to prevent of suppress toxic hyperparathyroidism.
    Nagode LA; Chew DJ; Podell M
    Vet Clin North Am Small Anim Pract; 1996 Nov; 26(6):1293-330. PubMed ID: 8911021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of phosphorus in hyperparathyroidism secondary to non-dialysed adult chronic renal insufficiency].
    Combe C; de Précigout V; Lasseur C; Lafage MH; Blanchetier V; Aparicio M
    Nephrologie; 1996; 17(3):149-56. PubMed ID: 9064563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary hyperparathyroidism in patients with chronic kidney failure].
    Fillastre JP; Robert M; Dubois D
    Sem Hop; 1973 Feb; 49(7):501-6. PubMed ID: 4350601
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular pathogenesis of secondary hyperparathyroidism in renal failure: basic and clinical aspects.
    Fukagawa M; Iwasaki Y
    Nephrol Dial Transplant; 1999; 14 Suppl 1():61-2. PubMed ID: 10048454
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
    Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
    J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in chronic kidney disease and mineral metabolism.
    Floege J; Kronenberg F; Froissart M
    JAMA; 2011 Jul; 306(2):159; author reply 159-60. PubMed ID: 21750291
    [No Abstract]   [Full Text] [Related]  

  • 9. Paricalcitol as compared with calcitriol in patients undergoing hemodialysis.
    Drüeke TB; McCarron DA
    N Engl J Med; 2003 Jul; 349(5):496-9. PubMed ID: 12890849
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bone disease in secondary hyperparathyroidism].
    Hayakawa H; Shigematsu T; Kazama JJ
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():324-9. PubMed ID: 15250317
    [No Abstract]   [Full Text] [Related]  

  • 11. Low doses of calcitriol or calcium carbonate for the prevention of hyperparathyroidism in predialysis patients?
    Fournier A; Oprisiu R; Moriniere P; El Esper N
    Nephrol Dial Transplant; 1996 Jul; 11(7):1493-5. PubMed ID: 8815432
    [No Abstract]   [Full Text] [Related]  

  • 12. Parathyroid function after kidney allografting.
    Tajima A; Ishikawa A; Ohta N; Suzuki K; Kawabe K; Aso Y
    Transplant Proc; 1996 Jun; 28(3):1629-30. PubMed ID: 8658814
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperparathyroidism in chronic renal failure.
    Furszyfer J; Goldsmith RS; Arnaud CD; Johnson WJ
    Lancet; 1970 Sep; 2(7672):571. PubMed ID: 4195233
    [No Abstract]   [Full Text] [Related]  

  • 14. Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?
    Klaus G; Mehls O; Hinderer J; Ritz E
    Lancet; 1991 Mar; 337(8744):800-1. PubMed ID: 1672430
    [No Abstract]   [Full Text] [Related]  

  • 15. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
    Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
    Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorus and protein restriction and parathyroid function in chronic renal failure.
    Combe C; Aparicio M
    Kidney Int; 1994 Nov; 46(5):1381-6. PubMed ID: 7853797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of growth hormone (GH) therapy on parathyroid hormone metabolism in a girl with GH deficient short stature and chronic renal failure.
    Fujisawa Y; Kida K
    J Pediatr Endocrinol Metab; 1996; 9(5):555-8. PubMed ID: 8961134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyrparathyroidism in renal insufficiency treated by hemodialysis and transplantation].
    Zech P; Perinetti M; Moskovtchenko JF; Pozet N; Meunier P; Traeger J
    Rein Foie; 1970; 13():223-50. PubMed ID: 4926838
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular basis for the management of secondary hyperparathyroidism in chronic renal failure.
    Fukagawa M; Yi H; Fukuda N; Kurokawa K
    Artif Organs; 1995 Dec; 19(12):1210-4. PubMed ID: 8967876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.
    Teng M; Wolf M; Lowrie E; Ofsthun N; Lazarus JM; Thadhani R
    N Engl J Med; 2003 Jul; 349(5):446-56. PubMed ID: 12890843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.